Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

Externe Organisationen

  • University of California at Davis
  • Stiftung Tierärztliche Hochschule Hannover
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)19-29
Seitenumfang11
FachzeitschriftProstaglandins Leukotrienes and Essential Fatty Acids
Jahrgang89
Ausgabenummer1
PublikationsstatusVeröffentlicht - Juli 2013

Abstract

Oxylipins, the oxidation products of unsaturated fatty acids (FA), are potent endogenous mediators being involved in the regulation of various biological processes such as inflammation, pain and blood coagulation. Compared to oxylipins derived from arachidonic acid (AA) by cyclooxygenase action, i.e. prostanoides, only limited information is available about the endogenous levels of hydroxy-, epoxy- and dihydroxy-FA of linoleic acid (LA), AA, α-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in humans. Particularly, it is unknown how metabolic disorders affect endogenous oxylipin levels in humans. Therefore, in the present study we compared the serum concentrations of 44 oxylipins in 20 normolipidemic with 20 hyperlipidemic (total cholesterol >200 mg/dl; LDL-C>130 mg/dl; TG>150 mg/dl) men (age 29-51 y). The serum concentration varied strongly among subjects. For most hydroxy-, epoxy- and dihydroxy-FA the concentrations were comparable to those in plasma reported in earlier studies. Despite the significant change in blood lipid levels the hyperlipidemic group showed only minor differences in oxylipin levels. The hyperlipidemic subjects had a slightly higher serum concentration of 8,9-DiHETrE, 5-HEPE, 10,11-DiHDPE, and a lower concentration of 12,13-DiHOME, 12-HETE, 9,10-DiHODE, and 12,13-DiHODE compared to normolipidemic subjects. Overall the hydroxy-, epoxy- and dihydroxy-FA levels were not changed suggesting that mild combined hyperlipidemia has no apparent effect on the concentration of circulating oxylipins. By contrast, serum levels of several hydroxy-, epoxy-, and dihydroxy-FA are dependent on the individual status of the parent FA. Particularly, a strong correlation between the EPA content in the erythrocyte membrane and the serum concentration of EPA derived oxylipins was observed. Given that the synthesis of EPA from other n-3 FA in humans is low; this suggests that oxylipin levels can be directly influenced by the diet.

Zitieren

Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men. / Schuchardt, Jan Philipp; Schmidt, Simone; Kressel, Gaby et al.
in: Prostaglandins Leukotrienes and Essential Fatty Acids, Jahrgang 89, Nr. 1, 07.2013, S. 19-29.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Schuchardt JP, Schmidt S, Kressel G, Dong H, Willenberg I, Hammock BD et al. Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men. Prostaglandins Leukotrienes and Essential Fatty Acids. 2013 Jul;89(1):19-29. doi: 10.1016/j.plefa.2013.04.001
Download
@article{7fd288087c144bdfaea47c6b02ada984,
title = "Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men",
abstract = "Oxylipins, the oxidation products of unsaturated fatty acids (FA), are potent endogenous mediators being involved in the regulation of various biological processes such as inflammation, pain and blood coagulation. Compared to oxylipins derived from arachidonic acid (AA) by cyclooxygenase action, i.e. prostanoides, only limited information is available about the endogenous levels of hydroxy-, epoxy- and dihydroxy-FA of linoleic acid (LA), AA, α-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in humans. Particularly, it is unknown how metabolic disorders affect endogenous oxylipin levels in humans. Therefore, in the present study we compared the serum concentrations of 44 oxylipins in 20 normolipidemic with 20 hyperlipidemic (total cholesterol >200 mg/dl; LDL-C>130 mg/dl; TG>150 mg/dl) men (age 29-51 y). The serum concentration varied strongly among subjects. For most hydroxy-, epoxy- and dihydroxy-FA the concentrations were comparable to those in plasma reported in earlier studies. Despite the significant change in blood lipid levels the hyperlipidemic group showed only minor differences in oxylipin levels. The hyperlipidemic subjects had a slightly higher serum concentration of 8,9-DiHETrE, 5-HEPE, 10,11-DiHDPE, and a lower concentration of 12,13-DiHOME, 12-HETE, 9,10-DiHODE, and 12,13-DiHODE compared to normolipidemic subjects. Overall the hydroxy-, epoxy- and dihydroxy-FA levels were not changed suggesting that mild combined hyperlipidemia has no apparent effect on the concentration of circulating oxylipins. By contrast, serum levels of several hydroxy-, epoxy-, and dihydroxy-FA are dependent on the individual status of the parent FA. Particularly, a strong correlation between the EPA content in the erythrocyte membrane and the serum concentration of EPA derived oxylipins was observed. Given that the synthesis of EPA from other n-3 FA in humans is low; this suggests that oxylipin levels can be directly influenced by the diet.",
keywords = "12-Hydroxy-5,8,10,14-eicosatetraenoic Acid/analogs & derivatives, Adult, Arachidonic Acid/blood, Eicosapentaenoic Acid/analogs & derivatives, Fatty Acids, Omega-3/blood, Fatty Acids, Unsaturated/blood, Humans, Hyperlipidemias/blood, Male, Middle Aged, alpha-Linolenic Acid/blood",
author = "Schuchardt, {Jan Philipp} and Simone Schmidt and Gaby Kressel and Hua Dong and Ina Willenberg and Hammock, {Bruce D} and Andreas Hahn and Schebb, {Nils Helge}",
note = "Funding information: This study was supported by a Marie Curie Career Integration Grant to NHS, a Grant of the German Federal Ministry of Education and Research (BMBF) to AH, a Kekul{\'e} Ph.D. fellowship of the Fonds der Chemischen Industrie to IW and grants of US National Institutes of Health (NIH) , Environmental Health (NIEHS, P42ES004699 and R01ES002710 ) and Diabetes and Digestive and Kidney Diseases (NIDDK, U24DK097154 ) and the West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC) to BDH. BDH is a George and Judy Marcus Senior Fellow of the American Asthma Association.",
year = "2013",
month = jul,
doi = "10.1016/j.plefa.2013.04.001",
language = "English",
volume = "89",
pages = "19--29",
journal = "Prostaglandins Leukotrienes and Essential Fatty Acids",
issn = "0952-3278",
publisher = "Churchill Livingstone",
number = "1",

}

Download

TY - JOUR

T1 - Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men

AU - Schuchardt, Jan Philipp

AU - Schmidt, Simone

AU - Kressel, Gaby

AU - Dong, Hua

AU - Willenberg, Ina

AU - Hammock, Bruce D

AU - Hahn, Andreas

AU - Schebb, Nils Helge

N1 - Funding information: This study was supported by a Marie Curie Career Integration Grant to NHS, a Grant of the German Federal Ministry of Education and Research (BMBF) to AH, a Kekulé Ph.D. fellowship of the Fonds der Chemischen Industrie to IW and grants of US National Institutes of Health (NIH) , Environmental Health (NIEHS, P42ES004699 and R01ES002710 ) and Diabetes and Digestive and Kidney Diseases (NIDDK, U24DK097154 ) and the West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC) to BDH. BDH is a George and Judy Marcus Senior Fellow of the American Asthma Association.

PY - 2013/7

Y1 - 2013/7

N2 - Oxylipins, the oxidation products of unsaturated fatty acids (FA), are potent endogenous mediators being involved in the regulation of various biological processes such as inflammation, pain and blood coagulation. Compared to oxylipins derived from arachidonic acid (AA) by cyclooxygenase action, i.e. prostanoides, only limited information is available about the endogenous levels of hydroxy-, epoxy- and dihydroxy-FA of linoleic acid (LA), AA, α-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in humans. Particularly, it is unknown how metabolic disorders affect endogenous oxylipin levels in humans. Therefore, in the present study we compared the serum concentrations of 44 oxylipins in 20 normolipidemic with 20 hyperlipidemic (total cholesterol >200 mg/dl; LDL-C>130 mg/dl; TG>150 mg/dl) men (age 29-51 y). The serum concentration varied strongly among subjects. For most hydroxy-, epoxy- and dihydroxy-FA the concentrations were comparable to those in plasma reported in earlier studies. Despite the significant change in blood lipid levels the hyperlipidemic group showed only minor differences in oxylipin levels. The hyperlipidemic subjects had a slightly higher serum concentration of 8,9-DiHETrE, 5-HEPE, 10,11-DiHDPE, and a lower concentration of 12,13-DiHOME, 12-HETE, 9,10-DiHODE, and 12,13-DiHODE compared to normolipidemic subjects. Overall the hydroxy-, epoxy- and dihydroxy-FA levels were not changed suggesting that mild combined hyperlipidemia has no apparent effect on the concentration of circulating oxylipins. By contrast, serum levels of several hydroxy-, epoxy-, and dihydroxy-FA are dependent on the individual status of the parent FA. Particularly, a strong correlation between the EPA content in the erythrocyte membrane and the serum concentration of EPA derived oxylipins was observed. Given that the synthesis of EPA from other n-3 FA in humans is low; this suggests that oxylipin levels can be directly influenced by the diet.

AB - Oxylipins, the oxidation products of unsaturated fatty acids (FA), are potent endogenous mediators being involved in the regulation of various biological processes such as inflammation, pain and blood coagulation. Compared to oxylipins derived from arachidonic acid (AA) by cyclooxygenase action, i.e. prostanoides, only limited information is available about the endogenous levels of hydroxy-, epoxy- and dihydroxy-FA of linoleic acid (LA), AA, α-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in humans. Particularly, it is unknown how metabolic disorders affect endogenous oxylipin levels in humans. Therefore, in the present study we compared the serum concentrations of 44 oxylipins in 20 normolipidemic with 20 hyperlipidemic (total cholesterol >200 mg/dl; LDL-C>130 mg/dl; TG>150 mg/dl) men (age 29-51 y). The serum concentration varied strongly among subjects. For most hydroxy-, epoxy- and dihydroxy-FA the concentrations were comparable to those in plasma reported in earlier studies. Despite the significant change in blood lipid levels the hyperlipidemic group showed only minor differences in oxylipin levels. The hyperlipidemic subjects had a slightly higher serum concentration of 8,9-DiHETrE, 5-HEPE, 10,11-DiHDPE, and a lower concentration of 12,13-DiHOME, 12-HETE, 9,10-DiHODE, and 12,13-DiHODE compared to normolipidemic subjects. Overall the hydroxy-, epoxy- and dihydroxy-FA levels were not changed suggesting that mild combined hyperlipidemia has no apparent effect on the concentration of circulating oxylipins. By contrast, serum levels of several hydroxy-, epoxy-, and dihydroxy-FA are dependent on the individual status of the parent FA. Particularly, a strong correlation between the EPA content in the erythrocyte membrane and the serum concentration of EPA derived oxylipins was observed. Given that the synthesis of EPA from other n-3 FA in humans is low; this suggests that oxylipin levels can be directly influenced by the diet.

KW - 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid/analogs & derivatives

KW - Adult

KW - Arachidonic Acid/blood

KW - Eicosapentaenoic Acid/analogs & derivatives

KW - Fatty Acids, Omega-3/blood

KW - Fatty Acids, Unsaturated/blood

KW - Humans

KW - Hyperlipidemias/blood

KW - Male

KW - Middle Aged

KW - alpha-Linolenic Acid/blood

U2 - 10.1016/j.plefa.2013.04.001

DO - 10.1016/j.plefa.2013.04.001

M3 - Article

C2 - 23694766

VL - 89

SP - 19

EP - 29

JO - Prostaglandins Leukotrienes and Essential Fatty Acids

JF - Prostaglandins Leukotrienes and Essential Fatty Acids

SN - 0952-3278

IS - 1

ER -

Von denselben Autoren